Attention Deficit Hyperactivity Disorder (ADHD) Market Report

Global and Region Attention Deficit Hyperactivity Disorder (ADHD) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：221
  • REPORT CODE：GMM917490
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Attention Deficit Hyperactivity Disorder (ADHD) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Attention Deficit Hyperactivity Disorder (ADHD)market, defines the market attractiveness level of Attention Deficit Hyperactivity Disorder (ADHD) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Attention Deficit Hyperactivity Disorder (ADHD) industry, describes the types of Attention Deficit Hyperactivity Disorder (ADHD) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Attention Deficit Hyperactivity Disorder (ADHD) market and the development prospects and opportunities of Attention Deficit Hyperactivity Disorder (ADHD) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Attention Deficit Hyperactivity Disorder (ADHD) market in Chapter 13.

    By Player:

    • Shire

    • Johnson & Johnson

    • Supernus Pharmaceuticals

    • Neos Therapeutics

    • Pfizer

    • Alcobra

    • Novartis

    • Eli Lilly

    • Curemark

    • Noven Pharmaceuticals

    By Type:

    • Stimulants

    • Non-Stimulants

    By End-User:

    • Specialty Clinics

    • Hospital

    • Retail

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Attention Deficit Hyperactivity Disorder (ADHD) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Attention Deficit Hyperactivity Disorder (ADHD) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Attention Deficit Hyperactivity Disorder (ADHD) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Attention Deficit Hyperactivity Disorder (ADHD) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Attention Deficit Hyperactivity Disorder (ADHD) Market Analysis and Outlook to 2022

    • 7.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption (2017-2022)

    • 7.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption (2017-2022)

    • 7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption (2017-2022)

    • 7.4 China Attention Deficit Hyperactivity Disorder (ADHD) Consumption (2017-2022)

    • 7.5 Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption (2017-2022)

    • 7.6 India Attention Deficit Hyperactivity Disorder (ADHD) Consumption (2017-2022)

    • 7.7 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption (2017-2022)

    8 Region and Country-wise Attention Deficit Hyperactivity Disorder (ADHD) Market Analysis and Outlook to 2028

    • 8.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast (2022-2028)

    • 8.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast (2022-2028)

    • 8.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast (2022-2028)

    • 8.4 China Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast (2022-2028)

    • 8.5 Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast (2022-2028)

    • 8.6 India Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast (2022-2028)

    • 8.7 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast (2022-2028)

    9 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Outlook by Types and Applications to 2022

    • 9.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Stimulants Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-Stimulants Consumption and Growth Rate (2017-2022)

    • 9.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Consumption and Growth Rate (2017-2022)

    10 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Outlook by Types and Applications to 2028

    • 10.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Stimulants Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-Stimulants Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Consumption Forecast and Growth Rate (2022-2028)

    11 Global Attention Deficit Hyperactivity Disorder (ADHD) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Competitive Analysis

    • 14.1 Shire

      • 14.1.1 Shire Company Details

      • 14.1.2 Shire Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Shire Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.2 Johnson & Johnson

      • 14.2.1 Johnson & Johnson Company Details

      • 14.2.2 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.3 Supernus Pharmaceuticals

      • 14.3.1 Supernus Pharmaceuticals Company Details

      • 14.3.2 Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.4 Neos Therapeutics

      • 14.4.1 Neos Therapeutics Company Details

      • 14.4.2 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.6 Alcobra

      • 14.6.1 Alcobra Company Details

      • 14.6.2 Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.7 Novartis

      • 14.7.1 Novartis Company Details

      • 14.7.2 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.9 Curemark

      • 14.9.1 Curemark Company Details

      • 14.9.2 Curemark Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Curemark Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • 14.10 Noven Pharmaceuticals

      • 14.10.1 Noven Pharmaceuticals Company Details

      • 14.10.2 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Attention Deficit Hyperactivity Disorder (ADHD)

    • Figure Attention Deficit Hyperactivity Disorder (ADHD) Picture

    • Table Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption by Country (2017-2022)

    • Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)

    • Table Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)

    • Figure China Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)

    • Figure Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)

    • Figure India Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption and Growth Rate (2017-2022)

    • Figure Global Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast by Country (2022-2028)

    • Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Attention Deficit Hyperactivity Disorder (ADHD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stimulants Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Stimulants Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Consumption and Growth Rate (2017-2022)

    • Figure Global Stimulants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Stimulants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Attention Deficit Hyperactivity Disorder (ADHD) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Attention Deficit Hyperactivity Disorder (ADHD) Export by Region (Top 5 Countries) (2017-2028)

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Supernus Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Neos Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Alcobra (Foundation Year, Company Profile and etc.)

    • Table Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Curemark (Foundation Year, Company Profile and etc.)

    • Table Curemark Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curemark Attention Deficit Hyperactivity Disorder (ADHD) Product and Service

    • Table Noven Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US